Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Numinus Wellness ( (TSE:NUMI) ) has issued an announcement.
Numinus Wellness Inc. provided an update regarding its management cease trade order (MCTO) related to the delayed filing of its audited annual financial statements and related documents for the fiscal year ending August 31, 2024. The company, which has been granted an MCTO by the British Columbia Securities Commission, is working diligently to complete the filings by January 28, 2025, while maintaining compliance with alternative information guidelines under NP 12-203. This situation does not affect shareholders’ ability to trade securities, and the company is not facing any insolvency issues or undisclosed material information.
More about Numinus Wellness
Numinus Wellness Inc. is a leading company in the mental health care industry, focusing on innovative and evidence-based treatments. It specializes in developing and delivering psychedelic-assisted therapies aimed at healing conditions like depression, anxiety, trauma, pain, and substance use. Numinus is at the forefront of integrating these therapies into mainstream clinical practice, contributing to a transformative approach in mental health care.
YTD Price Performance: 12.50%
Average Trading Volume: 681,621
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$14.5M
Find detailed analytics on NUMI stock on TipRanks’ Stock Analysis page.
